Adapalene 0-1% gel has low skin irritation potential even when applied immediately after washing

British Journal of Dermatology, Supplement

Volumn 139, Issue 52, 1998, Pages 23-25

  Dunlap, F E ^a   Baker, M D ^a   Plott, R T ^a   Verschoore, M ^a  

^a Argus Research Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ISOTRETINOIN; RETINOIC ACID;

ACNE VULGARIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERANCE; DRY SKIN; ERYTHEMA; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG ERUPTIONS; FEMALE; GELS; HUMANS; MALE; NAPHTHALENES; SKIN CARE;

EID: 0031686292     PISSN: 0366077X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.1390s2023.x     Document Type: Article

References (8)

1. Kligman AM. The treatment of acne with topical retinoids: one man's opinion. J Am Acad Dermatol 1997; 36: S92-5.
2. Verschoore M, Poncet M. Czernielewski J et al. Adapalcne 0-1% gel has low skin-irritation potential. J Am Acad Dennatol 1997: 36: S105-9.
3. Caron D, Sorba V, Kcrrouche N et al. Split-face comparison of adapalene (M% gel and tretinoin 0-025% gel in acne patients. J Am Acad Dennatol 1997; 36: S110-12.
4. Caron D, Sorba V, Clucas A et al Skin tolerance of adapalene 0-.1% gel in combination with other topical antiacne treatments. J Am Acad Dcrmatol 1997; 36: SI 13-15.
5. Clucas A, Verschoore M, Sorba V et al Adapalene 0-1% gel is better tolerated than tretinoin 0-025% gel in acne patients. J Am Acad Dennatol 1997: 36: SI 16-18.
6. Leyden JJ. Therapy for acne vulgaris. N Engl J Alcd 1997; 336: 1156-62.
7. Heel RC, Brodgen RN. Speight TM et al Vitamin A acid: a review of its pharmacological properties and therapeutic use in the topical treatment of acne vulgaris. Drugs 1977; 14: 401-19.
8. Effendy I, \Veltfriend S, Patil S. et al Differential irritant skin responses to topical retinoic acid and sodium lauryl sulphate: alone and in crossover design. Br ] Dennatol 1996; 134: 424-30.